An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...
A simple blood test can predict who will suffer from a debilitating bowel disease later in life, paving the way for early ...
In the third quarter of 2025, Mirador closed a $250 million Series B financing, bringing total capital raised to more than $650 million since the company launched in March 2024. The proceeds enable ...
Background: The pathogenesis of ulcerative colitis (UC) involves genetic susceptibility and immune dysregulation. However, a more comprehensive understanding of its underlying mechanisms is still ...
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3b ...
In a study published in Nature Immunology on January 6, a research team led by Prof. Qian Youcun from the Shanghai Institute ...
RIKEN scientists uncover how tobacco smoke alters gut bacteria, revealing potential new treatments for some types of ...
Researchers reveal a novel natural “decoy receptor” that protects against inflammatory bowel disease
A research team led by Prof. QIAN Youcun from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences identified a new member of the human IL -17 receptor ...
Switching to a second TNF inhibitor in inflammatory bowel disease may raise the risk for immune-mediated inflammatory ...
Background: Ulcerative colitis (UC) is a chronic inflammatory disease with highly variable symptoms and severity. Prognostic models for UC support precision medicine by enabling personalized treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback